Emotion-focused therapy as a transdiagnostic treatment for depression, anxiety and related disorders: Protocol for an initial feasibility randomised control trial.
Loading...
Authors
Timulak, Ladislav
Keogh, Daragh
McElvaney, James
Schmitt, Sonja
Hession, Natalie
Timulakova, Katarina
Jennings, Ciaran
Ward, Fiona
Issue Date
2020-02-13
Type
Journal Article
Language
en
Keywords
EFT-T , Emotion-focused therapy , anxiety , depression , protocol , transdiagnostic
Alternative Title
Abstract
Depression, anxiety and related disorders, including obsessive-compulsive disorders and trauma/stressor related disorders, have high prevalence, chronic courses and cause significant impairment. These disorders are also highly co-morbid, and appear to share etiology and maintenance factors. Recent developments have seen the emergence of transdiagnostic approaches that systematically address the common/shared features of these disorders. A key advantage of transdiagnostic approaches is that they can reduce the pressure on mental health professionals to be proficient in a plethora of single-disorder focused treatments. Currently almost all transdiagnostic approaches come from cognitive-behavioural therapy (CBT). However, not all clients prefer or benefit from CBT. Emotion-focused therapy (EFT) represents an evidence-based alternative to CBT. This study aims to examine a transdiagnostic adaptation of EFT (EFT-T) as a treatment for depression, anxiety and related disorders. The current study is a randomised controlled trial that aims to establish the efficacy of EFT-T vs. wait-list control in the treatment of depression, anxiety and related disorders. Up to 40 clients presenting in a psychology/counselling service will be randomly assigned to two conditions: EFT-T (n=20) and wait-list control, with delayed intervention (n=20). Primary outcome measures will be the Overall Anxiety Severity and Impairment Symptoms, the Overall Depression Severity and Impairment Symptoms, and the Clinical Outcome in Routine Evaluation - Outcome Measure. Disorder specific self-report measures will also be used to assess the main symptomatology of respective primary diagnoses. Clients will be assessed prior to therapy, at week 16, at end of therapy, and at 6 months follow-up. This study aims to provide an initial test of EFT-T as a transdiagnostic treatment for depression, anxiety and related disorders. It will provide estimates of effects sizes that can inform power calculations for a comparative trial, comparing EFT-T to a standard transdiagnostic treatment, CBT. ISRCTN11430110; registered on 07 January 2019.
Description
Citation
Timulak, L., Keogh, D., McElvaney, J., Schmitt, S., Hession, N., Timulakova, K., Jennings, C., & Ward, F. (2020). Emotion-focused therapy as a transdiagnostic treatment for depression, anxiety and related disorders: Protocol for an initial feasibility randomised control trial. HRB open research, 3, 7. https://doi.org/10.12688/hrbopenres.12993.1
Publisher
License
Copyright: © 2020 Timulak L et al.
Journal
HRB open research
Volume
3
Issue
PubMed ID
DOI
10.12688/hrbopenres.12993.1
10.1001/jamapsychiatry.2017.2164
10.1176/appi.ajp.157.10.1599
10.1037/a0036216
10.1002/jts.22059
10.1037//0021-843x.110.4.585
10.1111/j.1469-7610.2009.02099.x
10.1016/j.cpr.2010.04.009
10.1080/14779757.2017.1330701
10.1192/bjp.180.1.51
10.1080/jmh.9.3.247.255
10.3758/bf03193146
10.1017/s0033291701004056
10.1080/14733145.2013.808682
10.1080/10503300600589456
10.1001/archpsyc.1989.01810110048007
10.1001/archpsyc.1989.01810110054008
10.1080/10503309812331332317
10.1037//0022-006x.59.1.12
10.1093/med-psych/9780190255541.003.0001
10.3310/hta4190
10.1046/j.1525-1497.2001.016009606.x
10.1159/000414022
10.1002/cpp.693
10.1680/ijct.2008.1.3.181
10.1016/s0887-6185(02)00134-2
10.1017/s003329170400412x
10.1016/j.cpr.2015.06.002
10.1016/j.cpr.2011.01.008
10.1007/s00737-012-0325-8
10.1002/da.20182
10.1023/A:1007891716593
10.1037/12077-000
10.1016/j.brat.2006.12.003
10.5127/pr.036014
10.1037/ccp0000166
10.1176/ajp.154.11.1571
10.1016/s0022-3956(01)00028-0
10.1001/archinte.166.10.1092
10.1016/0005-7967(96)00036-8
10.4324/9781315760650
10.7910/DVN/Z8ZESJ
10.4324/9781315527253
10.1037/pst0000128
10.1186/s13063-018-2892-0
10.1007/s10879-019-09426-7
10.1037/0022-006x.71.4.773
10.1037/0000018-001
10.1002/da.20735
10.1371/journal.pone.0150205
10.1016/j.cpr.2014.06.002
10.1136/bmj.i5239
10.1037/0000041-000
10.1037/12077-000
10.1001/jamapsychiatry.2017.2164
10.1176/appi.ajp.157.10.1599
10.1037/a0036216
10.1002/jts.22059
10.1037//0021-843x.110.4.585
10.1111/j.1469-7610.2009.02099.x
10.1016/j.cpr.2010.04.009
10.1080/14779757.2017.1330701
10.1192/bjp.180.1.51
10.1080/jmh.9.3.247.255
10.3758/bf03193146
10.1017/s0033291701004056
10.1080/14733145.2013.808682
10.1080/10503300600589456
10.1001/archpsyc.1989.01810110048007
10.1001/archpsyc.1989.01810110054008
10.1080/10503309812331332317
10.1037//0022-006x.59.1.12
10.1093/med-psych/9780190255541.003.0001
10.3310/hta4190
10.1046/j.1525-1497.2001.016009606.x
10.1159/000414022
10.1002/cpp.693
10.1680/ijct.2008.1.3.181
10.1016/s0887-6185(02)00134-2
10.1017/s003329170400412x
10.1016/j.cpr.2015.06.002
10.1016/j.cpr.2011.01.008
10.1007/s00737-012-0325-8
10.1002/da.20182
10.1023/A:1007891716593
10.1037/12077-000
10.1016/j.brat.2006.12.003
10.5127/pr.036014
10.1037/ccp0000166
10.1176/ajp.154.11.1571
10.1016/s0022-3956(01)00028-0
10.1001/archinte.166.10.1092
10.1016/0005-7967(96)00036-8
10.4324/9781315760650
10.7910/DVN/Z8ZESJ
10.4324/9781315527253
10.1037/pst0000128
10.1186/s13063-018-2892-0
10.1007/s10879-019-09426-7
10.1037/0022-006x.71.4.773
10.1037/0000018-001
10.1002/da.20735
10.1371/journal.pone.0150205
10.1016/j.cpr.2014.06.002
10.1136/bmj.i5239
10.1037/0000041-000
10.1037/12077-000
ISSN
2515-4826